Taking Better Aim at Tumors

(DGIwire) – When it comes to treating cancer, chemotherapy and immunotherapy have proven to be powerful within certain limits. Take immunotherapy: Despite its great promise, it doesn’t help every patient to which it is given—and its track record of success is uneven among different cancers. So notes Douglas J. Swirsky, President and CEO of Rexahn […]

What’s Next in the Fight Against Pancreatic Cancer?

(DGIwire) – Sobering news from the world of medicine: More than 56,000 Americans will be diagnosed with pancreatic cancer in 2019, according to a recent estimate by the American Cancer Society. This represents a two percent increase over the previous year’s diagnoses. While the ACS also states that the disease’s five-year survival rate continues to […]

Pancreatic Cancer Treatment: Pharmaceuticals Point the Way

(DGIwire) – Recent discoveries are raising hopes for the prospects of patients who have been diagnosed with pancreatic cancer. Currently, as noted in a recent article published in STAT, just 20 percent of pancreatic patients survive one year after diagnosis and less than 10 percent make it to the five-year mark. However, advances in the […]

4 Questions to Ask About Pancreatic Cancer

(DGIwire) – Located behind the stomach, the pancreas plays a vital role in creating enyzmes for digestion and hormones like insulin, according to the American Cancer Society. It is also a common site of cancer. For anyone who has been diagnosed with pancreatic cancer—or who knows someone who has—getting basic facts quickly from a qualified […]

close